高危子宫内膜癌微创与开腹子宫切除术的比较
这项多中心倾向匹配研究比较了高危子宫内膜癌患者微创与开腹子宫切除术的无病生存,匹配队列5年无病生存率开腹组53.4%对微创组54.6%(P=.82),微创手术与更差的无病生存、总生存或复发率均无关。
要点
- 高危子宫内膜癌中微创与开腹手术的5年无病生存率无显著差异。
- 微创手术与开腹手术相比,总生存和复发率均无显著差异。
- 使用举宫器与更差的无病生存、总生存和复发率均无关。
核心结论
- 在高危子宫内膜癌患者中,微创手术与开腹手术的肿瘤学结局无差异。
研究设计与样本
- 多中心倾向匹配研究,纳入1999年1月至2016年6月在两中心接受子宫切除术、双侧输卵管卵巢切除术和分期的626例高危子宫内膜癌患者。
- 高危子宫内膜癌包括3级子宫内膜样癌、浆液性癌、透明细胞癌、未分化癌或癌肉瘤,伴任何肌层浸润。
- 按手术方式预先分组,基于潜在混杂因素计算倾向评分,采用最近邻技术1:1匹配。
主要发现
- 626例 eligible 患者中,263例(42%)接受微创手术,363例(58%)接受开腹手术。
- 匹配队列中,5年无病生存率开腹组为53.4%(95%CI 45.6-60.5%),微创组为54.6%(95%CI 46.6-61.8%),P=.82。
- 与开腹手术相比,微创手术与更差的无病生存无关(HR 0.85,95%CI 0.63-1.16;P=.30)。
- 与开腹手术相比,微创手术与更差的总生存无关(HR 1.04,95%CI 0.73-1.48;P=.81),与更差的复发率无关(HR 0.99,95%CI 0.69-1.44;P=.99)。
- 使用举宫器与更差的无病生存无关(HR 1.01,95%CI 0.65-1.58,P=.96),与更差的总生存无关(HR 1.18,95%CI 0.71-1.96,P=.53),与更差的复发率无关(HR 1.12,95%CI 0.67-1.87;P=.66)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare disease-free survival between minimally invasive surgery and open surgery in patients with high-risk endometrial cancer. METHODS: We conducted a multicentric, propensity-matched study of patients with high-risk endometrial cancer who underwent hysterectomy, bilateral salpingo-oophorectomy, and staging between January 1999 and June 2016 at two centers. High-risk endometrial cancer included grade 3 endometrioid, serous, clear cell, undifferentiated carcinoma or carcinosarcoma with any myometrial invasion. Patients were categorized a priori into two groups based on surgical approach, propensity scores were calculated based on potential confounders and groups were matched 1:1 using nearest neighbor technique. Cox hazard regression analysis and Kaplan-Meier curves evaluated the association of surgical technique with survival. RESULTS: Of 626 eligible patients, 263 (42%) underwent minimally invasive surgery and 363 (58%) underwent open surgery. In the matched cohort, there were no differences in disease-free survival rates at 5 years between open (53.4% [95% CI 45.6-60.5%]) and minimally invasive surgery (54.6% [95% CI 46.6-61.8]; P=.82). Minimally invasive surgery was not associated with worse disease-free survival (hazard ratio [HR] 0.85, 95% CI 0.63-1.16; P=.30), overall survival (HR 1.04, 95% CI 0.73-1.48, P=.81), or recurrence rate (HR 0.99; 95% CI 0.69-1.44; P=.99) compared with open surgery. Use of uterine manipulator was not associated with worse disease-free survival (HR 1.01, 95% CI 0.65-1.58, P=.96), overall survival (HR 1.18, 95% CI 0.71-1.96, P=.53), or recurrence rate (HR 1.12, 95% CI 0.67-1.87; P=.66). CONCLUSION: There was no difference in oncologic outcomes comparing minimally invasive and open surgery among patients with high-risk endometrial cancer.
引用
- Segarra-Vidal B, Dinoi G, Zorrilla-Vaca A, et al. Minimally Invasive Compared With Open Hysterectomy in High-Risk Endometrial Cancer. Obstet Gynecol. 2021. PMID: 34735382. doi:10.1097/AOG.0000000000004606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。